NCT02920333

Brief Summary

This study is to compare the efficacy of two types of non-invasive brain stimulation (NIBS) in lower limb motor function recovery in stroke patients. The intervention will be tDCS (transcraniel direct current stimulation) or rTMS (repetitive transcraniel magnetic stimulation) plus conventional gait training for 10 days over 2 weeks. The study hypothesizes that:

  1. 1.When combined with conventional gait training, NIBS could improve the walking ability of stroke survivors.
  2. 2.NIBS will modulate cortex activity of the brain area representing the lower limbs.
  3. 3.The effects of NIBS might be related to some genetic factors. 45 subjects will be randomly divided into 3 groups, receiving tDCS plus conventional gait training, or rTMS plus conventional gait training, or sham tDCS plus conventional gait training.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Feb 2016

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2014

Completed
1.1 years until next milestone

Study Start

First participant enrolled

February 1, 2016

Completed
8 months until next milestone

First Posted

Study publicly available on registry

September 30, 2016

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
Last Updated

April 22, 2022

Status Verified

April 1, 2022

Enrollment Period

4.4 years

First QC Date

December 21, 2014

Last Update Submit

April 14, 2022

Conditions

Keywords

stroketranscraniel direct current stimulationrepetitive transcraniel magnetic stimulationrehabilitationlower extremities

Outcome Measures

Primary Outcomes (1)

  • changes of " gait parameters" from baseline to post-intervention and 4 weeks after intervention

    Gait analysis will be performed using the Tekscan walkway system. Subjects will be required to walk on a mat at their comfort speed. Gait parameters including step and stride parameters, symmetry scores, velocity, and cadence temporal will be collected and recorded while the subject is walking along the walkway.

    before intervention, immediately after intervention, 4 weeks after intervention

Secondary Outcomes (7)

  • changes of "cortical excitability measured by TMS" from baseline to post-intervention and 4 weeks after intervention

    before intervention, immediately after intervention, 4 weeks after intervention

  • changes of " Blood BDNF level" from baseline to post-intervention and 4 weeks after intervention

    before intervention, immediately after intervention, 4 weeks after intervention

  • changes of " cortical excitability measured by fMRI" from baseline to post-intervention and 4 weeks after intervention

    before intervention, immediately after intervention, 4 weeks after intervention

  • changes of " Psychological and cognitive properties" from baseline to post-intervention and 4 weeks after intervention

    before intervention, immediately after intervention, 4 weeks after intervention

  • changes of walking speed measured by "10 meter walk test" from baseline to post-intervention and 4 weeks after intervention

    before intervention, immediately after intervention, 4 weeks after intervention

  • +2 more secondary outcomes

Study Arms (3)

tDCS+ rehab training

EXPERIMENTAL

tDCS will be applied 10 days, followed by conventional rehab training. Anodal stimulation will be conducted at the intensity of 2 mA and last for 20 minutes over the affected primary motor cortex of cortical representation of the tibialis anterior muscle.

Procedure: conventional rehab trainingDevice: tDCS

rTMS+ rehab training

EXPERIMENTAL

rTMS will be applied 10 days, followed by conventional rehab training. Subjects will receive 10 Hz rTMS, and a total of 1200 pulses will be delivered for one treatment session.

Procedure: conventional rehab trainingDevice: rTMS

sham tDCS+ rehab training

SHAM COMPARATOR

The same stimulation parameters as tDCS treatment will be employed for the sham stimulation. However, the current will be applied for 30 seconds only, to give subjects the sensation of the stimulation.

Procedure: conventional rehab trainingDevice: sham tDCS

Interventions

Conventional rehab training will be conducted daily for 10 days, after NIBS intervention.

rTMS+ rehab trainingsham tDCS+ rehab trainingtDCS+ rehab training
tDCSDEVICE

tDCS will be applied 10 days, followed by conventional rehab training. Stimulation will be conducted at the intensity of 2 mA and last for 20 minutes. anode will be placed over the affected primary motor cortex (M1) of cortical representation of the tibialis anterior muscle (TA), while the cathode will be used as reference electrode and placed over the forehead of the unaffected side.

tDCS+ rehab training
rTMSDEVICE

rTMS will be applied 10 days, followed by conventional rehab training. Subjects will receive 10 Hz rTMS, and a total of 1200 pulses will be delivered for one treatment session.

rTMS+ rehab training
sham tDCSDEVICE

The same stimulation parameters as tDCS treatment will be employed for the sham stimulation. However, the current will be applied for 30 seconds only, to give subjects the sensation of the stimulation.

sham tDCS+ rehab training

Eligibility Criteria

Age21 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For subjects receiving intervention:
  • Male or female aged 21-80 years;
  • First ever haemorrhagic or ischaemic subcortical stroke of 3-6 months prior to study enrolment;
  • Functional Ambulatory Category 3 (requires not more than minimal assistance for walking);
  • Be able to provide informed consent.
  • For healthy subjects:
  • Male or female aged 21-80 years;
  • Physically healthy;
  • Be able to provide informed consent.

You may not qualify if:

  • For subjects receiving intervention:
  • Severe claustrophobia;
  • pregnancy;
  • cardiac pacemakers;
  • orthodontics (braces);
  • metal implant;
  • presence of other non MRI-compatible ferromagnetic implants;
  • history of epilepsy;
  • sensorimotor disturbance due to other causes other than stroke;
  • severe pain in the lower limbs affecting gait;
  • uncontrolled medical conditions including hypertension, diabetes mellitus and unstable angina;
  • major depression and a history of psychotic disorders (Subject with BDI score more than 30 will be excluded).
  • For healthy subjects:
  • Cardiovascular diseases;
  • Diabetes mellitus;
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National University Hospital

Singapore, 119228, Singapore

Location

MeSH Terms

Conditions

Stroke

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Effie Chew, MD

    National University Hospital, Singapore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2014

First Posted

September 30, 2016

Study Start

February 1, 2016

Primary Completion

July 1, 2020

Study Completion

July 1, 2020

Last Updated

April 22, 2022

Record last verified: 2022-04

Locations